对接受tixagevimab/cilgavimab SARS-CoV2暴露前预防的内科免疫抑制患者进行6个月随访

{"title":"对接受tixagevimab/cilgavimab SARS-CoV2暴露前预防的内科免疫抑制患者进行6个月随访","authors":"M. Liagre, J. Chambord, M. Lahouati, I. Crubezy, S. Djabarouti, E. Lazaro","doi":"10.1016/j.revmed.2023.04.181","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":94122,"journal":{"name":"La Revue de medecine interne","volume":"49 1","pages":"A224 - A224"},"PeriodicalIF":0.0000,"publicationDate":"2023-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Suivi à 6 mois d’une cohorte de patients immunodéprimés en médecine interne bénéficiant d’une prophylaxie préexposition au SARS-CoV2 par tixagevimab/cilgavimab\",\"authors\":\"M. Liagre, J. Chambord, M. Lahouati, I. Crubezy, S. Djabarouti, E. Lazaro\",\"doi\":\"10.1016/j.revmed.2023.04.181\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":94122,\"journal\":{\"name\":\"La Revue de medecine interne\",\"volume\":\"49 1\",\"pages\":\"A224 - A224\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2023-06-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"La Revue de medecine interne\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1016/j.revmed.2023.04.181\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"La Revue de medecine interne","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1016/j.revmed.2023.04.181","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}